Effects of OPC-51803, a novel, nonpeptide vasopressin V2-receptor agonist, on micturition frequency in Brattleboro and aged rats

Journal of Pharmacological Sciences

Volumn 93, Issue 4, 2003, Pages 484-488

  Nakamura, Shigeki ^a   Hirano, Takahiro ^a   Yamamura, Yoshitaka ^a   Itoh, Shuji ^a   Kondo, Kazumi ^a   Mori, Toyoki ^a   Kambe, Toshimi ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Antidiuresis; Micturition frequency; Nonpeptide; OPC 51803; Vasopressin V2 agonist

Indexed keywords

2 [1 (2 CHLORO 4 (1 PYRROLIDINYL)BENZOYL) 2,3,4,5 TETRAHYDRO 1H 1 BENZAPIN 5 YL] N ISOPROPYLACETAMIDE; OPC 51803; UNCLASSIFIED DRUG; VASOPRESSIN DERIVATIVE; VASOPRESSIN V2 RECEPTOR;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES INSIPIDUS; DIURESIS; DRUG EFFECT; FEMALE; MALE; MICTURITION; MICTURITION DISORDER; NONHUMAN; POLYURIA; RAT; RAT STRAIN; URINE FLOW RATE; URINE INCONTINENCE; URINE VOLUME;

AGING; ANIMALS; BENZAZEPINES; DIURESIS; FEMALE; MALE; PYRROLIDINES; RATS; RATS, BRATTLEBORO; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; SPECIES SPECIFICITY; TIME FACTORS; URINATION;

EID: 1042281037     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.93.484     Document Type: Article

References (24)

1. 2-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes. Br J Pharmacol. 2000;129:1700-1706.
2. 2-receptor agonist, OPC-51803, administered orally to rats. J Pharmacol Exp Ther. 2000;295:1005-1011.
3. Asplund R, Aberg HE. Micturition habits of older people. Voiding frequency and urine volumes. Scand J Urol Nephrol. 1992;26:345-349.
4. Blanker MH, Bohnen AM, Groeneveld FP, Bernsen RM, Prins A, Ruud Bosch JL. Normal voiding patterns and determinants of increased diurnal and nocturnal voiding frequency in elderly men. J Urol. 2000;164:1201-1205.
5. Donahue JL, Lowenthal DT. Nocturnal polyuria in the elderly person. Am J Med Sci. 1997;314:232-238.
6. Okamura K, Usami T, Nagahama K, Maruyama S, Mizuta E. "Quality of life" assessment of urination in elderly Japanese men and women with some medial problems using International Prostate Symptom Score and King's Health Questionnaire. Eur Urol. 2002;41:411-419.
7. Homma Y, Yamaguchi O, Kageyama S, Nizhizawa O, Yoshida M, Kawabe K. Nocturia in the adult: Classification on the basis of largest voided volume and nocturnal urine production. J Urol. 2000;163:777-781.
8. Van Kerrebroeck P, Abrams P, Chaikin D, et al. The standardzation of terminology in nocturia: Report from the standardization subcommittee of the International Continence Society. BJU Int. 2002;90 Suppl 3:11-15.
9. Weiss JP, Blaivas JG, Stember DS, Brooks MM. Nocturia in adults: Etiology and classification. Neurourol Urodyn. 1998;17:467-472.
10. Weiss JP, Blaivas JG. Nocturia. J Urol. 2000;163:5-12.
11. Andersson KE, Chapple CR. Oxybutynin and the overactive bladder. World J Urol. 2001;19:319-323.
12. Jonas U, Hofner K, Madersbacher H, Holmdahl TH. Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: Urodynamic evaluation. The International Study Group. World J Urol. 1997;15:144-151.
13. Neveus T. Oxybutynin, desmopressin and enuresis. J Urol. 2001;166:2459-2462.
14. Aikawa T, Kasahara T, Uchiyama M. Circadian variation of plasma arginine vasopressin concentration, or arginine vasopressin in enuresis. Scand J Urol Nephrol Suppl. 1999;202:47-49.
15. Asplund R, Aberg H. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med. 1991;229:131-134.
16. Lackgren G, Neveus T, Stenberg A. Diurnal plasma vasopressin and urinary output in adolescents with monosymptomatic nocturnal enuresis. Acta Paediatr. 1997;86:385-390.
17. Ouslander JG, Nasr SZ, Miller M, et al. Arginine vasopressin levels in nursing home residents with nighttime urinary incontinence. J Am Geriatr Soc. 1998;46:1274-1279.
18. Rittig S, Knudsen UB, Norgaard JP, Pedersen EB, Djurhuus JC. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol. 1989;256:F664-F671.
19. Eika B, Levin RM, Longhurst PA. Comparison of urinary bladder function in rats with hereditary diabetes insipidus, streptozotocin-induced diabetes mellitus, and nondiabetic osmotic diuresis. J Urol. 1994;151:496-502.
20. Malmgren A, Uvelius B, Andersson KE, Andersson PO. Urinary bladder function in rats with hereditary diabetes insipidus: A cystometrical and in vitro evaluation. J Urol. 1992;148:930-934.
21. Geelen G, Corman B. Relationship between vasopressin and renal concentrating ability in aging rats. Am J Physiol. 1992;262:R826-R833.
22. Zbuzek VK, Zbuzek V, Wu W. The effect of aging on vasopressin system in Fisher 344 rats. Exp Gerontol. 1983;18:305-311.
23. Cannon A, Carter PG, McConnell AA, Abrams P. Desmopressin in the treatment of nocturnal polyuria in the male. BJU International. 1999;84:20-24.
24. Hilton P, Stanton SL. The use of desmopressin (DDAVP) in noctural urinary frequency in the female. Br J Urol. 1982; 54:252-255.